Pareto Analysis on 42 Cases of Drug-Induced Thrombocytopenia

WU Furong; YANG Zhaoyi; LI Min; ZHANG Lei; NING Lijuan

doi:10.14009/j.issn.1672-2124.2021.02.027

您当前的位置：

首页 >

文章列表页 >

Pareto Analysis on 42 Cases of Drug-Induced Thrombocytopenia

更新时间：2022-10-08

- Pareto Analysis on 42 Cases of Drug-Induced Thrombocytopenia
- Vol. 21, Issue 2, Pages: 240-243(2021)
- 作者机构：
  
  中国科学技术大学附属第一医院药剂科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2021.02.027
  CLC： R969.3
- Published：2021，
扫描看全文
[1]吴芙蓉,杨昭毅,李民,张蕾,宁丽娟.42例药源性血小板减少症的帕累托分析[J].中国医院用药评价与分析,2021,21(02):240-243.

WU Furong, YANG Zhaoyi, LI Min, et al. Pareto Analysis on 42 Cases of Drug-Induced Thrombocytopenia. [J]. 21(2):240-243(2021)
[1]吴芙蓉,杨昭毅,李民,张蕾,宁丽娟.42例药源性血小板减少症的帕累托分析[J].中国医院用药评价与分析,2021,21(02):240-243. DOI： 10.14009/j.issn.1672-2124.2021.02.027.

WU Furong, YANG Zhaoyi, LI Min, et al. Pareto Analysis on 42 Cases of Drug-Induced Thrombocytopenia. [J]. 21(2):240-243(2021) DOI： 10.14009/j.issn.1672-2124.2021.02.027.

摘要

目的:了解中国科学技术大学附属第一医院（以下简称"我院"）药源性血小板减少症（drug-induced thrombocytopenia

DITP）的特点

为防范临床用药风险和提高用药合理性提供参考。方法:收集2018年1月至2020年7月我院上报的42例DITP住院患者的病历资料

利用帕累托法对上报人员职业、患者年龄与性别、药品种类、给药方式、临床表现及处理措施等进行统计分析。结果:42例DITP中

以药师上报为主（38例）;男性患者、女性患者各21例;患者年龄主要集中于>18～<80岁

为主要因素;涉及9类药物23种药品

其中抗肿瘤药引起DITP病例数最多（15例）

抗肿瘤药、抗菌药物、抗癫痫药和抗血小板药为主要因素;涉及5种给药方式

其中静脉滴注为主要因素; DITP多发生于用药后1～14 d（26例）

为主要因素; 12例DITP仅停药未对症处理

30例DITP给予对症治疗

主要为重组人白介素-11与输注血小板联合治疗。结论:临床使用可能引起DITP的药物时

应加强安全用药意识

密切监测血小板计数

尽早发现DITP并对症治疗

以确保临床用药安全。

Abstract

OBJECTIVE: To probe into the characteristics drug-induced thrombocytopenia（ DITP） in the First Affiliated Hospital of University of Science and Technology of China（ hereinafter referred to as "our hospital"）

so as to provide reference for preventing clinical medication risk and improving rational medication.METHODS: Data of the42 cases of DITP patients reported by our hospital from Jan.2018 to Jul.2020 were collected and analyzed by Pareto method in terms of occupation

age and gender

categories of drug

administration route

clinical manifestations and treatment measures.RESULTS: Among the 42 cases of DITP

mainly reported by pharmacists（ 38 cases）; there were21 male and 21 female patients; mainly aged > 18-< 80 years old; 9 categories including 23 kinds of drugs were involved

of which antineoplastics had caused the most DITP cases（ 15 cases）

antineoplastics

antibiotics

antiepileptics and antiplatelet drugs were the main factors; 5 ways of administration were involved

of which intravenous drip was the main factor; the DITP was mostly occurred during 1-14 days after medication（ 26 cases）; 12 cases if DIPT were treated with drug withdrawal without symptomatic treatment

30 cases were given symptomatic treatment

mainly given recombinant human interleukin-11（ rhIL-11） combined with platelet transfusion for treatment.CONCLUSIONS: When clinical application of drugs that may cause DITP

awareness of safe medication should be strengthened

platelet counts should be closely monitored

DITP should be detected as soon as possible and given symptomatic treatment to ensure clinical medication safety.

关键词

药源性血小板减少症帕累托法药品不良反应

Keywords

Drug-induced thrombocytopeniaPareto methodAdverse drug reaction

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Investigation and Analysis of 280 Cases of Drug-Induced Thrombocytopenia

Analysis on 120 Cases of Adverse Drug Reactions Caused by Traditional Chinese Medicine Injection

Effects of Prescription Pre-Review on Application of Nonsteroidal Anti-Inflammatory Drug After Orthopedic Surgery

Pharmaceutical Care for Severe Drug-Induced Thrombocytopenia Induced by Levofloxacin

Related Author

SHEN Xiaolan

ZHAO Ping

SHEN Chenyu

LI Xin

LIU Lihua

CHEN Zhihong

PENG Jia

FENG Yufei

Related Institution

Dept.of Pharmacy,Jiangsu Shengze Hospital Affiliated to Nanjing Medical University

College of Pharmacy,Kangda College of Nanjing Medical University

Dept.of Pharmacy, the Third Hospital of Changsha

Division for Supervision and Administration of Drug Use and Adverse Reactions, Changsha Administration for Market Regulation

Dept.of Pharmacy,Peking University People’s Hospital

⁰